Advertisements



Flex Pharma Shares Plunge After Biotech Ends 2 Clinical Trials, Announces 60% Workforce Cut

Flex Pharma Inc (NASDAQ: FLKS) shares are slumping on above-average volume Wednesday following a release from the company announcing the scrapping of two clinical trials and the explo read more.....»»

Category: blogSource: benzingaJun 13th, 2018

Peninsula biotech sheds 20% of jobs to focus on drugs closer to finish line

Cancer-fighting Five Prime Therapeutics Inc. will cut about 20 percent of its 209-person workforce as it tries to push more drugs into clinical trials and advance those already being tested on patients. The move — the first large-scale layoff in th.....»»

Category: topSource: bizjournalsJan 15th, 2019

The Week Ahead In Biotech: Conferences, Clinical Trials

The new year kick started with a bumper deal in the pharma space, with Bristol-Myers Squibb Co (NYSE: BMY) agreeing to buy Celgene Corporation (NASDAQ: read more.....»»

Category: blogSource: benzingaJan 6th, 2019

The Week Ahead In Biotech: ASH Presentations Pick Up Pace, PDUFA Dates, Clinical Trials And IPOs

Large-cap pharma stocks are seeing some upward momentum and are on track to f.....»»

Category: blogSource: benzingaDec 2nd, 2018

The Week Ahead In Biotech: ASH Presentations Pick Up Pace, PDUFA Dates, Clinical Trials And IPOs

Large-cap pharma stocks are seeing some upward momentum and are on track to finish the year with handsome gains. As the year draws to a close, it remains to be see.....»»

Category: personnelSource: nytDec 2nd, 2018

Why Gemphire Is Tuesday’s Big Biotech Loser

Gemphire shares were more than halved on Tuesday after the company provided an update in regards to the clinical hold on gemcabene with respect to clinical trials of longer than six months in........»»

Category: blogSource: 247wallstAug 7th, 2018

Flex Pharma Down on Workforce Reduction, Ends Phase II Study

Flex Pharma (FLKS) announced that the company is ending the phase II studies for its pipeline candidate FLX-787 in two indications. The company also plans to lower its workforce by about 60%. F.....»»

Category: smallbizSource: nytJun 14th, 2018

Flex Pharma to end Phase 2 trials, explore alternatives, cut workforce

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 13th, 2018

Mid-Afternoon Market Update: Dow Surges Over 700 Points; Flex Pharma Shares Spike Higher

Toward the end of trading Friday, the Dow traded up 3.39 percent to 23,455.03 while the NASDAQ climbed 4.45 percent to 6,751.09 The S&P also rose, gaining 3.54 percent to 2,534.46. Leading and Lagging Sectors read more.....»»

Category: blogSource: benzingaJan 4th, 2019

Flex Pharma Finds A Lifeline In Merger With Oncology Biotech Salarius Pharma

Biotech deal flow is continuing in the new year following Thursday's announcement of Bristol-Myers Squibb Co (NYSE: BMY)'s proposed $74-billion acquisition read more.....»»

Category: blogSource: benzingaJan 4th, 2019

Flex Pharma to merge with Salarius to accelerate development of cancer treatments

Flex Pharma Inc. said Friday it has reached an agreement to merge with privately held Salarius Pharmaceuticals LLC in a deal aimed at accelerating the clinical development of Salarius' pipeline of drugs for .....»»

Category: topSource: marketwatchJan 4th, 2019

GW Pharma"s stock jumps after J.P. Morgan initiates the cannabinoid company with a bullish rating

Shares of biotech GW .....»»

Category: topSource: marketwatchJan 2nd, 2019

The Ratings Game: Stitch Fix shares sink 26% as focus shifts from new clients to selling more to existing ones

Stitch Fix shares plunge after the company announces a shift in strategy that spooks investors......»»

Category: topSource: marketwatchDec 11th, 2018

Marinus Pharma"s Postpartum Depression Candidate Aces Midstage Trials

A handful of micro-cap stocks were making moves Monday, with the release of clinical trial results being the catalyst. read more.....»»

Category: blogSource: benzingaDec 10th, 2018

Ra Pharma Shares Rally: What You Need To Know

Ra Pharmaceuticals Inc (NASDAQ: RARX) shares are surging higher Monday morning, reacting to an announcement by the company concerning clinical trial results of its autoimmune disorder drug. read more.....»»

Category: blogSource: benzingaDec 10th, 2018

Here"s What Pushed Novavax Stock Up 17.6% in November

What happened Shares of Novavax NASDAQ NVAX 160 a clinical stage biotech developing new vaccines gained 17 6 in November according to data from S amp P Global Market Intelligence Investors looking forward to upcoming clinical trial results for two.....»»

Category: futuresSource: nasdaqDec 8th, 2018

The Week Ahead In Biotech: Conferences, Clinical Trials And Earnings

Biotech stocks pulled back in last week. Incidentally, some large-cap biotec.....»»

Category: blogSource: benzingaDec 8th, 2018

The Week Ahead In Biotech: Conferences, Clinical Trials And Earnings

Biotech stocks pulled back in last week. Incidentally, some large-cap .....»»

Category: smallbizSource: nytDec 8th, 2018

The Week Ahead In Biotech: ASH 2018, PDUFA Dates, Clinical Trials And Earnings

Notwithstanding the s.....»»

Category: blogSource: benzingaNov 25th, 2018

The Week Ahead In Biotech: ASH 2018, PDUFA Dates, Clinical Trials And Earnings

Notwithstanding the scanty news flow, biotech stocks came under intense s.....»»

Category: earningsSource: benzingaNov 25th, 2018

RBS Shares Plunge As Bank Announces $130 Million "Hard Brexit" Contingency Buffer

With Brexit talks effectively frozen as Theresa May battles her cabinet mi.....»»

Category: blogSource: zerohedgeOct 28th, 2018